Angus C. Russell's Net Worth

$1.17 Million

Estimate Recalculated Sep 8, 2024 07:38PM EST

Who is Angus C. Russell?

Angus C. Russell has an estimated net worth of $1.17 Million. This is based on reported shares across multiple companies, which include Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., Mallinckrodt plc, TherapeuticsMD, Inc., QUESTCOR PHARMACEUTICALS INC, INTERMUNE INC, and Structure Therapeutics Inc..

SEC CIK

Angus C. Russell's CIK is 0001534002

Past Insider Trading and Trends

2013 was Angus C. Russell's most active year for acquiring shares with 9 total transactions. Angus C. Russell's most active month to acquire stocks was the month of April. 2014 was Angus C. Russell's most active year for disposing of shares, totalling 11 transactions. Angus C. Russell's most active month to dispose stocks was the month of August. 2015 saw Angus C. Russell paying a total of $487,600.50 for 280,108 shares, this is the most they've acquired in one year. In 2014 Angus C. Russell cashed out on 68,303 shares for a total of $1,269,692.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56

Investor

Angus C. Russell owns 51,506 units of Common Stock which is worth $337,879.36. From 2021 to 2024 Angus C. Russell acquired a total of 51,506 shares in Revance Therapeutics, Inc. at a cost of $100,741.12.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.09%
15K
—
—
51.51K
May 1
Form 4
+10.72%
3.53K
—
—
36.51K
May 3
Form 4/A
—
0
—
—
0
May 4
Form 4
+22.51%
6.06K
—
—
32.97K
May 4
Form 4
+31.20%
6.4K
$15.74
$100,741.12
26.91K
Dec 13
Form 4
+24.32%
4.01K
—
—
20.51K
May 5
Form 4
+57.14%
6K
—
—
16.5K
May 14
Form 4
+75.00%
4.5K
—
—
10.5K
May 9
Form 4
+100.00%
3K
—
—
6K
May 10
Form 4
∞
3K
—
—
3K
May 11
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
May 7
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $0.8778

Investor

Angus C. Russell owns 87,500 units of Common Shares, no par value which is worth $76,807.50. From 2014 to 2024 Angus C. Russell acquired a total of 74,720 shares in Lineage Cell Therapeutics, Inc. at a cost of $245,884.00, Angus also disposed a total of 4,720 shares of Lineage Cell Therapeutics, Inc. equalling to $14,018.40.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
+29.63%
20K
$2.59
$40,365.60
87.5K
Jun 29
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 1
Form 4
+285.71%
50K
$3.83
$191,500.00
67.5K
Nov 6
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

Mallinckrodt plc (MNKTQ) Snapshot price: $0.04

Investor

Angus C. Russell owns 21,530 units of Ordinary shares, $0.20 par value which is worth $861.20. Angus C. Russell used to own units in Ordinary Shares but no longer holds any shares there. In the year 2014 Angus C. Russell filed a total of 15 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
-100.00%
-51.79K
$0.13
-$6,665.24
0
Nov 12
Form 4
-18.87%
-12.04K
$2.96
-$35,644.32
51.79K
May 13
Form 4
+30.70%
14.99K
$15.21
-$178,930.44
63.83K
May 15
Form 4
+115.18%
26.14K
—
—
48.84K
May 16
Form 4
-10.19%
-2.58K
$15.68
-$40,391.68
22.7K
Mar 1
Form 4
-1.85%
-476.00
$37.37
-$17,788.12
25.27K
Oct 1
Form 4
+15.41%
3.44K
$51.55
-$117,843.30
25.75K
Mar 1
Form 4
+4.97%
1.06K
—
—
22.31K
Oct 1
Form 4
+5.13%
1.04K
—
—
21.25K
Jul 21
Form 4
+21.54%
3.58K
$55.69
-$25,506.02
20.22K
Mar 16
Form 4
+22.02%
3K
$131.21
-$79,513.26
16.63K
Mar 19
Form 4/A
∞
13.63K
—
—
13.63K
Aug 14
Form 4
∞
21.53K
—
—
21.53K
Aug 14
Form 3
—
0
—
—
0
No matching records found

TherapeuticsMD, Inc. (TXMD) Snapshot price: $1.9

Investor

Angus C. Russell owns 5,792 units of Common Stock which is worth $11,004.80. In the year 2015 Angus C. Russell filed a total of 16 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 29
Form 4
+52.10%
1.98K
—
—
5.79K
Aug 18
Form 4
+103.60%
96.86K
—
—
190.36K
Aug 10
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 18
Form 4
+11.98%
10K
$2.77
$27,700.00
93.5K
Aug 23
Form 4
+72.16%
35K
$2.83
$98,900.00
83.5K
Aug 14 - Aug 15
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Dec 21
Form 4
—
0
—
—
0
Dec 17
Form 4
+38.57%
13.5K
$5.98
$80,784.00
48.5K
Aug 25
Form 4
∞
35K
$6.15
$215,316.50
35K
May 12
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found

QUESTCOR PHARMACEUTICALS INC No price found

Investor

Angus C. Russell used to own units in Common Stock but no longer holds any shares there. In the year 2013 Angus C. Russell filed a total of 5 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.36K
—
—
0
Aug 14
Form 4/A
∞
5.11K
—
—
5.11K
Jun 8
Form 4
+63.55%
3.25K
$46.15
$149,985.55
8.36K
Jun 14
Form 4
∞
5.11K
—
—
5.11K
Jun 8
Form 3
—
0
—
—
0
No matching records found